ReNu: Neurofibromatosis Type 1 (NF1) Plexiform Neurofibromas trial
The purpose of this study is to determine the effectiveness of the study drug at improving a plexiform neurofibroma (PN) that is causing significant issues in people with neurofibromatosis Type 1 (NF1). This study is for people 2 years of age and older
For more information contact:
Who can participate?
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?